PALATIN TECHNOLOGIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
PALATIN TECHNOLOGIES, INC. (PTN) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 0 shares for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2025-11-14
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-09-30 was 0.00 shares.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2024-06-30 was 5.30K shares.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2023-09-30 was 0.00 shares.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2025 was 0.00 shares.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2020 was 3.40M shares, a 123.93% increase from fiscal 2019.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2019 was 1.52M shares, a 69.12% decline from fiscal 2018.
- PALATIN TECHNOLOGIES, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2018 was 4.91M shares, a 53.96% increase from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month as first filed |
|---|---|---|---|---|---|
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-14 | |||
| 2025-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | 0.00 shares 10-K · filed 2025-09-23 | |||
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-14 | ||||
| 2024-06-30 | 5.30K shares derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-14 | 5.30K shares 10-Q · filed 2025-11-14 | 517.80K shares 10-K · filed 2024-09-30 | ||
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-15 | ||||
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | 4.78K shares 10-Q · filed 2025-11-14 | 425.75K shares 10-K · filed 2023-09-28 | |||
| 2022-12-31 | 0.00 shares 10-Q · filed 2023-02-14 | ||||
| 2022-06-30 | 1.21K shares 10-Q · filed 2025-11-14 | 131.35K shares 10-K · filed 2022-09-22 | |||
| 2021-06-30 | 1.90K shares derived: 10-Q 12 month − 10-Q 9 month · filed 2025-11-14 | 1.90K shares derived: sum of 2 quarters · filed 2025-11-14 | 1.90K shares derived: sum of 3 quarters · filed 2025-11-14 | 1.90K shares 10-Q · filed 2025-11-14 | 3.24M shares 10-K · filed 2021-09-28 |
| 2021-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2021-05-14 | 0.00 shares 10-Q · filed 2021-05-14 | 3.40M shares derived: sum of 4 quarters · filed 2021-09-28 | |
| 2020-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | 0.00 shares 10-Q · filed 2021-02-16 | 3.40M shares derived: sum of 3 quarters · filed 2021-09-28 | 3.40M shares derived: sum of 4 quarters · filed 2021-09-28 | |
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-16 | 3.40M shares derived: sum of 2 quarters · filed 2021-09-28 | 3.40M shares derived: sum of 3 quarters · filed 2021-09-28 | 3.40M shares derived: sum of 4 quarters · filed 2021-09-28 | |
| 2020-06-30 | 3.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | 3.40M shares derived: sum of 2 quarters · filed 2021-09-28 | 3.40M shares derived: sum of 3 quarters · filed 2021-09-28 | 3.40M shares 10-K · filed 2021-09-28 | |
| 2020-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | 0.00 shares derived: sum of 2 quarters · filed 2020-05-11 | 0.00 shares 10-Q · filed 2020-05-11 | 1.52M shares derived: sum of 4 quarters · filed 2020-09-25 | |
| 2019-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-10 | 0.00 shares 10-Q · filed 2020-02-10 | 1.52M shares derived: sum of 3 quarters · filed 2020-09-25 | 1.52M shares derived: sum of 4 quarters · filed 2020-09-25 | |
| 2019-09-30 | 0.00 shares 10-Q · filed 2019-11-12 | 1.52M shares derived: sum of 2 quarters · filed 2020-09-25 | 1.52M shares derived: sum of 3 quarters · filed 2020-09-25 | 1.52M shares derived: sum of 4 quarters · filed 2020-09-25 | |
| 2019-06-30 | 1.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | 1.52M shares derived: sum of 2 quarters · filed 2020-09-25 | 1.52M shares derived: sum of 3 quarters · filed 2020-09-25 | 1.52M shares 10-K · filed 2020-09-25 | |
| 2019-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | 0.00 shares derived: sum of 2 quarters · filed 2019-05-09 | 0.00 shares 10-Q · filed 2019-05-09 | ||
| 2018-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-11 | 0.00 shares 10-Q · filed 2019-02-11 | |||
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-11-09 | ||||
| 2018-06-30 | 4.91M shares 10-K · filed 2020-09-25 | ||||
| 2017-06-30 | 3.19M shares 10-K · filed 2019-09-12 | ||||
| 2016-06-30 | 2.30M shares 10-K · filed 2018-09-13 | ||||
| 2015-06-30 | 785.80K shares 10-K · filed 2017-09-25 | ||||
| 2014-06-30 | 603.40K shares 10-K · filed 2016-09-19 | ||||
| 2013-06-30 | 757.50K shares 10-K · filed 2015-09-18 | ||||
| 2012-06-30 | 0.00 shares 10-K · filed 2014-09-12 | ||||
| 2011-06-30 | 705.00K shares 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |